Literature DB >> 15901938

Immunohistochemistry of p53, Bcl-2, and Ki-67 as predictors of chemosensitivity.

Mitsuyoshi Itaya1, Jiro Yoshimoto, Kuniaki Kojima, Seiji Kawasaki.   

Abstract

Chemosensitivity is affected by molecular biological factors, including factors related to the induction of apoptosis and the activity of proliferation. We analyzed immunohistochemically the expression of p53, Bcl-2, and Ki-67 in various types of cancers and assessed the correlation between this expression and chemosensitivity. Moreover, we investigated whether the expression of these factors could be a useful predictor for the clinical response to chemotherapy. Study subjects comprised 63 preoperative patients with untreated malignant tumors (9 with esophageal cancer, 12 with stomach cancer, 12 with colon cancer, 16 with liver cancer, and 14 with breast cancer). Immunohistochemical staining (the labeled streptavidin biotin technique: LSAB method) was used to assess expression of p53 protein, Bcl-2 protein, and Ki-67. A chemosensitivity test was carried out with the histoculture drug response assay method using four drugs: mitomycin C, 5-fluorouracil, doxorubicin hydrochloride (ADM), and cisplatin (CDDP). Immunohistochemical studies for p53 were found to be useful for predicting chemosensitivity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15901938     DOI: 10.1385/1-59259-869-2:213

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


  2 in total

1.  Myricetin enhance chemosensitivity of 5-fluorouracil on esophageal carcinoma in vitro and in vivo.

Authors:  Lei Wang; Jianfang Feng; Xiaonan Chen; Wei Guo; Yuwen Du; Yuanyuan Wang; Wenqiao Zang; Shijie Zhang; Guoqiang Zhao
Journal:  Cancer Cell Int       Date:  2014-07-18       Impact factor: 5.722

2.  Identification of Sensitivity Predictors of Neoadjuvant Chemotherapy for the Treatment of Adenocarcinoma of Gastroesophageal Junction.

Authors:  Shoumiao Li; Baozhong Li; Jiaxiang Wang; Da Zhang; Zhiqiang Liu; Zhizhong Zhang; Wei Zhang; Yunjie Wang; Dongxiao Bai; Jianyun Guan; Yong Zhang
Journal:  Oncol Res       Date:  2017-01-02       Impact factor: 5.574

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.